On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- p53 is a tumor suppressor
- Evidence that p53 is a tumor suppressor
- Additional evidence that p53 is a tumor suppressor
- Half of all human cancers carry p53 mutations
- p53 is a sequence-specific transcription factor
- Schematic structure of p53 protein
- Example: the biological activities of p53
- Effect of temperature-sensitive p53 activation
- Induction of cell death by activated p53
- Activated p53 induces apoptosis in leukemic cells
- p53 is activated by oncogenic stress
- p53 is activated by various cellular stress types
- Induction of p53 by DNA damage (cisplatin)
- How is p53 activated?
- Some p53 target genes
- Activity of transcriptional activation-deficient p53
- Translocation of p53 in response to DNA damage
- Transcription activity in response to DNA damage
- Mitochondrially targeted p53
- Mitochondrially targeted p53 induces apoptosis
- Transcriptional activation-deficient and wt p53
- PUMA releases p53 from Bcl-xL
- Integrated apoptotic activities of p53
- How is p53 activity restrained in absence of stress
- MDM2 - a negative regulator of p53
- Basic facts about MDM2
- How does MDM2 inactivate p53?
- MDM2 promotes degradation of p53
- p53 levels determine its fate
- p53-MDM2 negative autoregulatory feedback loop
- Disrupting the p53-MDM2 feedback loop
- p53 in evolution
- p53 transcriptional activity in drosophila embryo
- Effect of dominant negative p53 activity in the fly
- C.elegans p53 is required for germ cell apoptosis
- How is the outcome of p53 activation determined
- p53 activation: growth arrest or cell death?
- Induction of p21 by p53 can inhibit apoptosis
- Some p53 target genes are anti-apoptotic
- p53 mutations lead to different effects on its action
- Mutant p53 overexpression prevents apoptosis
- Mutant p53 protects cancer cells from killing
- Knock-down of mutant p53 restores killing
- Mutant p53 down-regulates surface CD95 protein
- Mutant p53 down-regulates the CD95 promoter
- p53-based cancer therapy
- p53-MDM2 binding
- Drugs that disrupt p53-mdm2 binding - Nutlin
- Nutlin induces p53 activation/ tumor regression
- PRIMA-1 affects mutant p53
- PRIMA-1 synergizes with cisplatin
- Summary
Topics Covered
- p53 as a tumor suppressor
- Regulation of transcription by p53
- Activation of p53 by oncogenic stress
- Transcriptional and non-transcriptional mechanisms for p53- mediated apoptosis
- Regulation of p53 by Mdm2
- Evolutionary conservation of p53 function
- Mutant p53 gain of function
- p53-based cancer therapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Oren, M. (2007, October 1). p53 and apoptosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/AYTF7064.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Moshe Oren has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.